MA27193A1 - Complexes et formulations pharmaceutiques sans gouts, directement compressibles, se dissolvant rapidement - Google Patents

Complexes et formulations pharmaceutiques sans gouts, directement compressibles, se dissolvant rapidement

Info

Publication number
MA27193A1
MA27193A1 MA27896A MA27896A MA27193A1 MA 27193 A1 MA27193 A1 MA 27193A1 MA 27896 A MA27896 A MA 27896A MA 27896 A MA27896 A MA 27896A MA 27193 A1 MA27193 A1 MA 27193A1
Authority
MA
Morocco
Prior art keywords
pharmaceutical formulations
complex
preparation
taste
complexes
Prior art date
Application number
MA27896A
Other languages
English (en)
Inventor
Wadhwa Hardeep
Original Assignee
M S Ind Swift Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M S Ind Swift Ltd filed Critical M S Ind Swift Ltd
Publication of MA27193A1 publication Critical patent/MA27193A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EXTRAIT DE L„INVENTION Un complexe effervescent qui est insipide, granuleux, directement compressible et stable composé d'une préparation de base ayant un goût amer, des formulations pharmaceutiques composées du complexe insipide de la préparation de base et des formes de dosage ainsi obtenues sont révélés. La préparation de base peut être le fexofenadine, et le complexe de la préparation de base peut être un complexe de fexofenadine-carbopol. Les procédures pour la préparation, l'isolation et la caractérisation du complexe insipide de la préparation de base ayant un goût amer et les procédures de la production des formulations pharmaceutiques sont révélées également.
MA27896A 2002-03-08 2004-10-08 Complexes et formulations pharmaceutiques sans gouts, directement compressibles, se dissolvant rapidement MA27193A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN207DE2002 2002-03-08

Publications (1)

Publication Number Publication Date
MA27193A1 true MA27193A1 (fr) 2005-01-03

Family

ID=27773181

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27896A MA27193A1 (fr) 2002-03-08 2004-10-08 Complexes et formulations pharmaceutiques sans gouts, directement compressibles, se dissolvant rapidement

Country Status (7)

Country Link
US (1) US20030170310A1 (fr)
AU (1) AU2003209673B2 (fr)
BR (1) BRPI0308445A2 (fr)
MA (1) MA27193A1 (fr)
MX (1) MXPA04008737A (fr)
TN (1) TNSN04173A1 (fr)
WO (1) WO2003075829A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703673D0 (en) * 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles
GB0027357D0 (en) * 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
BRPI0409962A (pt) 2003-05-08 2006-04-25 Nektar Therapeutics Uk Ltd co-formulação particulada de uma substáncia ativa e um excipiente, composição farmacêutica ou nutricêutrica, produto farmacêutico ou nutricêutico, método para preparar uma co-formulação particulada de uma substáncia ativa e um excipiente, e, uso de uma substáncia ativa e um excipiente
US7282217B1 (en) * 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE602004023764D1 (de) * 2004-03-19 2009-12-03 Zentiva Kimyasal Ueruenler San Herstellung von lipid-beschichtetem cefuroxime axetil
US20070092553A1 (en) * 2005-10-21 2007-04-26 Pfab Lp Compositions and methods of making rapidly dissolving lonically masked formulations
EP2043613A1 (fr) * 2006-07-14 2009-04-08 Fmc Corporation Forme solide
ES2538082T3 (es) 2007-02-11 2015-06-17 Map Pharmaceuticals Inc Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios
WO2008114280A1 (fr) * 2007-03-21 2008-09-25 Lupin Limited Nouvelles compositions pharmaceutiques à dose réduite de fexofénadine et de pseudoéphédrine
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
RU2563623C2 (ru) 2009-12-02 2015-09-20 Апталис Фарма Лимитед Микрокапсулы фексофенадина и содержащие их композиции
EP2640736B1 (fr) 2010-11-19 2016-08-31 Cargill, Incorporated Procédé d'enrichissement de rebaudioside b et/ou de rebaudioside d dans des compositions de glycosides dérivés de stévia par chromatographie d'adsorption-désorption avec une résine adsorbante neutre macroporeuse
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
US20150010622A1 (en) * 2013-07-03 2015-01-08 R.P. Scherer Technologies, Llc Capsule formulation comprising fexofenadine
US11727516B2 (en) 2019-06-26 2023-08-15 PharmaCCX, Inc. System and methods for securing a drug therapy
GB2629127A (en) * 2022-08-31 2024-10-23 Novumgen Ltd An orodispersible tablet of fexofenadine and its process of preparation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5840529B2 (ja) * 1975-09-29 1983-09-06 明治製菓株式会社 ケイコウヨウセイザイノセイホウ
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
WO1994008576A1 (fr) * 1992-10-16 1994-04-28 Glaxo Group Limited Compositions a base de ranitidine masquant le gout de celle-ci
US6027746A (en) * 1997-04-23 2000-02-22 Warner-Lambert Company Chewable soft gelatin-encapsulated pharmaceutical adsorbates
FR2776302B1 (fr) * 1998-03-19 2002-04-12 Hoechst Marion Roussel Inc Nouveau procede de preparation de la fexofenadine
US6051585A (en) * 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
US6667026B1 (en) * 2002-03-15 2003-12-23 Pocono Falls, Inc. Allergic contact dermatitis treatment and composition therefor

Also Published As

Publication number Publication date
MXPA04008737A (es) 2005-07-13
AU2003209673B2 (en) 2007-10-18
WO2003075829A3 (fr) 2004-11-18
AU2003209673A1 (en) 2003-09-22
TNSN04173A1 (en) 2007-03-12
US20030170310A1 (en) 2003-09-11
WO2003075829A2 (fr) 2003-09-18
BRPI0308445A2 (pt) 2016-08-02

Similar Documents

Publication Publication Date Title
MA27193A1 (fr) Complexes et formulations pharmaceutiques sans gouts, directement compressibles, se dissolvant rapidement
MY127683A (en) Pharmaceutical tramadol salts
DE60231298D1 (de) Capsaicin-enthaltende missbrauchsichere pharmazeutische zusammensetzungen
BR0201714A (pt) Uso de hidroxiflavanonas para encobrir o sabor amargo
GEP20084442B (en) Compositions for the treatment of neurocerebrovascular disorders
MXPA03006476A (es) Composiciones farmaceuticas, formas de dosificacion y metodos para administracion oral de epotilonas.
WO2002080969A1 (fr) Remedes pour des maladies liees a l'arthrite chronique du nourrisson
WO2005065646A3 (fr) Compositions medicamenteuses et formes pharmaceutiques
MXPA04003439A (es) Compuestos de maleimida 3,4 disustituidos como antagonistas de receptor de quimiocina cxc.
WO2007070504A3 (fr) Compositions orales liquides de sumatriptan stables et de gout agreable
NO20043367L (no) Oralt farmasoytisk preparat
WO2002094774A3 (fr) Formes galeniques d'oxcarbazepine
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
DE122006000057I1 (de) Proteinhaltige Arzneimittel
WO2003047552A3 (fr) Composition pharmaceutique
WO2003086293A3 (fr) Preparation pharmaceutique de masquage de gout
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
MXPA03002807A (es) Estabilizacion de formulaciones solidas de farmacos.
MA26346A1 (fr) Compositions de preparation contenant des composes actifs au plan physiologique et instables aux acides et leur procede de production.
WO2003051398A8 (fr) Composition parenterale de paracetamol
WO2001080619A3 (fr) Composition pharmaceutique contenant du citalopram
WO2004098594A3 (fr) Forme posologique contenant du pantoprazole en tant qu'ingredient actif
WO2004087880A3 (fr) Composes et leur utilisation dans le traitement du diabete et troubles connexes
EP1800689A4 (fr) Préparation liquide d'un peptide physiologiquement actif
MY134019A (en) Aryl oxime-piperazines useful as ccr5 antagonists